OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Adler Group S.A. ADLER GROUP SA/  LU1250154413  /

London International
2024-04-19  9:10:47 AM Chg. +0.0001 Volume Bid5:40:02 PM Ask5:40:02 PM Market Capitalization Dividend Y. P/E Ratio
0.1967EUR +0.05% 5,590
Turnover: 1.0800		 -Bid Size: - -Ask Size: - 20.21 mill.EUR 186.05% -
GlobeNewswire 04-10 SBA Recognizes 2024 Small Business Investment Companies of the Year
GlobeNewswire 04-09 1stDibs Announces the 1stDibs 50 for 2024
GlobeNewswire 04-04 BioSig Engages Consulting Firm for Business Model Strategies
GlobeNewswire 03-18 SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
GlobeNewswire 03-14 SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Tria...
GlobeNewswire 03-13 NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromya...
GlobeNewswire 03-12 Flexera 2024 State of the Cloud: Managing Cloud Spending is the Top Challenge of Cloud Computing, wh...
GlobeNewswire 03-08 SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spect...
GlobeNewswire 03-06 SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
GlobeNewswire 02-29 SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dos...
GlobeNewswire 02-20 SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Cl...
GlobeNewswire 02-05 Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
GlobeNewswire 01-29 SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children...
Newsfile Corp 01-24 Whiskey Wise Group Launches an AI-driven App, Redefining the Landscape of Whiskey Casks in 2023.
GlobeNewswire 2023-12-21 Pomerantz LLP and Wolf Haldenstein Adler Freeman & Herz LLP Announce Proposed Class Action Settlemen...
GlobeNewswire 2023-12-01 Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
GlobeNewswire 2023-11-28 NCDT Marks Its Entry on MEXC Exchange
GlobeNewswire 2023-11-28 SciSparc Adopts Limited Duration Shareholder Rights Plan
GlobeNewswire 2023-11-28 SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Pro...
GlobeNewswire 2023-11-24 New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
GlobeNewswire 2023-11-09 Le Vian Launches New Mare Azzurro Collection
GlobeNewswire 2023-11-08 Le Vian Premieres November as Platinum Love Month
GlobeNewswire 2023-10-31 SciSparc Granted Patent from the Australian Patent Office for its Reduction of Opioids Use in Pain M...
GlobeNewswire 2023-10-10 BridgeBio Pharma Announces New England Journal of Medicine Publication of Positive Encaleret Proof-o...
GlobeNewswire 2023-10-03 SciSparc Granted European Patent for its Core Technology